Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Can Vet J ; 65(7): 638-642, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38952756

ABSTRACT

An 11-year-old neutered male large crossbreed dog was presented for investigation because of a 10-day history of progressive lethargy, hyporexia, and pyrexia. Physical and dermatological examinations were unremarkable. Blood biochemical analysis identified a marked total and ionized hypercalcemia and increased C-reactive protein concentration. Bicavitary computed tomography screening for causes of the dog's clinical and biochemical abnormalities identified a diffuse panniculitis. Histopathological examination of full-thickness skin biopsies was consistent with pyogranulomatous inflammation. Extensive histochemical staining revealed no infectious etiology. Complete clinical and biochemical remissions were observed after starting immunosuppressive, followed by tapering, doses of prednisolone, supporting an immune-mediated etiology. Key clinical message: Sterile, immune-mediated pyogranulomatous inflammation should remain a differential diagnosis for hypercalcemia in dogs. Significant dermatological disease may occur without visible abnormalities.


Panniculite pyogranulomateuse à médiation immunitaire avec hypercalcémie chez un chienUn grand chien croisé mâle castré de 11 ans a été présenté pour examen en raison d'antécédents de léthargie progressive, d'hyporexie et de pyrexie depuis 10 jours. Les examens physiques et dermatologiques étaient sans particularité. L'analyse biochimique du sang présentait une hypercalcémie totale et ionisée marquée et une concentration accrue de protéine C-réactive. Le dépistage par tomodensitométrie bicavitaire des causes des anomalies cliniques et biochimiques du chien a identifié une panniculite diffuse. L'examen histopathologique des biopsies cutanées de pleine épaisseur était compatible avec une inflammation pyogranulomateuse. Un examen par coloration histochimique extensive n'a révélé aucune étiologie infectieuse. Les rémissions cliniques et biochimiques complètes ont été observées après le début du traitement immunosuppresseur, suivies d'une diminution progressive des doses de prednisolone, confirmant une étiologie à médiation immunitaire.Message clinique clé:L'inflammation pyogranulomateuse stérile à médiation immunitaire doit rester un diagnostic différentiel de l'hypercalcémie chez le chien. Une maladie dermatologique importante peut survenir sans anomalies visibles.(Traduit par Dr Serge Messier).


Subject(s)
Dog Diseases , Hypercalcemia , Panniculitis , Animals , Dogs , Dog Diseases/diagnosis , Dog Diseases/drug therapy , Dog Diseases/pathology , Male , Panniculitis/veterinary , Panniculitis/diagnosis , Hypercalcemia/veterinary , Prednisolone/therapeutic use , Immunosuppressive Agents/therapeutic use
2.
Vet Radiol Ultrasound ; 65(1): 36-44, 2024 Jan.
Article in English | MEDLINE | ID: mdl-38111229

ABSTRACT

The phrenic lymph node (PLN) has been described in bovine, equine, and feline anatomic references but descriptions in canine anatomic references are currently lacking. Authors have observed a well-defined, soft tissue attenuating, contrast-enhancing structure in a location consistent with previous anatomic descriptions of the PLN in dogs that underwent thoracic CT for neoplastic staging. The aims of this two-part, retrospective/prospective, anatomic, prevalence study were (1) to describe the presence of a soft tissue structure close to the thoracic caudal vena cava, defined as the presumed PLN, in a series of dogs that underwent CT as part of the staging for metastatic disease; (2) to confirm the lymphatic origin of the presumed PLN in a dog through postmortem examination; (3) to assess the prevalence of the presumed PLN in a population of dogs that underwent thoracic CT or MRI for different clinical purposes; and (4) to assess the possibility to visualize the presumed PLN with ultrasonography. The lymphatic origin of the presumed PLN was confirmed by postmortem examination in one dog. The presumed PLN was visible in 29 of 777 canine CT examinations (prevalence 3.7%). The presumed PLN was not visible in 9 of 10 prospectively recruited ultrasound cases. Most dogs with visible presumed PLNs were large-medium breeds that were presented for neoplastic staging purposes. Findings indicated that a structure consistent with the previously reported anatomic features of PLN in cattle, horses, and cats may be detected with a low prevalence in canine CT and MRI examinations.


Subject(s)
Lymph Nodes , Animals , Dogs , Cats , Cattle , Horses , Retrospective Studies , Prospective Studies , Prevalence , Lymph Nodes/diagnostic imaging , Lymph Nodes/pathology , Ultrasonography/veterinary
3.
Vet Radiol Ultrasound ; 64(5): 834-843, 2023 Sep.
Article in English | MEDLINE | ID: mdl-37496364

ABSTRACT

Arterial enhancement is the commonly described characteristic of canine insulinomas in contrast-enhanced computed tomography (CECT). However, this finding is also reported as inconsistent. The main aim of this single-center retrospective observational study was to describe the contrast enhancement (CE) pattern of canine presumed and confirmed insulinomas and presumed metastases in three consecutive (early, mid, and late) arterial phases. Included dogs had a medical-record-based clinical or cytological/histopathological diagnosis of insulinoma and quadruple-phase CECT. The arterial phases were identified according to published literature. The arterial enhancement of confirmed and presumed lesions was assessed using a visual grading score. Twelve dogs with a total of 17 pancreatic nodules were analyzed. Three dogs had multiple pancreatic nodules and nine had solitary findings. Four insulinomas were histopathologically confirmed. Late arterial phase (LAP) images demonstrated the largest number of pancreatic nodules reaching the highest enhancement scores (n = 13, 76%). All analyzed dogs had CT evidence of arterially enhancing nodules in the liver (n = 12), seven in the hepatic, splenic, or colic lymph nodes, and three in the spleen. Three out of five sampled livers and three lymph nodes were metastatic. All sampled spleens were benign. Avid arterial enhancement was the most dominant feature of canine presumed and confirmed insulinomas and presumed metastases in quadruple-phase CECT. The highest enhancement scores were observed primarily in LAP, followed by MAP. Authors, therefore, recommend including LAP in the standard CT protocol for dogs with suspected pancreatic insulinomas.


Subject(s)
Insulinoma , Pancreatic Neoplasms , Animals , Dogs , Abdomen , Insulinoma/diagnostic imaging , Insulinoma/veterinary , Liver/pathology , Pancreatic Neoplasms/diagnostic imaging , Pancreatic Neoplasms/veterinary , Tomography, X-Ray Computed/veterinary , Tomography, X-Ray Computed/methods
4.
J Equine Vet Sci ; 94: 103240, 2020 11.
Article in English | MEDLINE | ID: mdl-33077099

ABSTRACT

An incidental osteochondritis dissecans (OCD) lesion was found in a left tarsus of a 3-year-old Freiberger stallion presented for a prepurchase examination. The lesion was best visualized on the dorsomedial-plantarolateral oblique and dorsoplantar projections. A standing computed tomographic examination confirmed a fragmentation of the dorsodistolateral aspect of the calcaneus. In suspected OCD lesions at the distal aspect of the talus or calcaneus, a dorsoplantar projection of the tarsus improves lesion localization and could be added to the standard radiographic protocol during OCD screenings. Computed tomography allowed more detailed evaluation of a not previously described calcaneal origin of this uncommon presumed OCD lesion in the equine tarsus.


Subject(s)
Calcaneus , Horse Diseases , Osteochondritis Dissecans , Talus , Animals , Calcaneus/diagnostic imaging , Horse Diseases/diagnostic imaging , Horses , Male , Osteochondritis Dissecans/diagnostic imaging , Osteochondritis Dissecans/veterinary , Radiography , Talus/diagnostic imaging , Tomography, X-Ray Computed/veterinary
SELECTION OF CITATIONS
SEARCH DETAIL
...